Why are biosimilars much more complex than generics? / Por que os biossimilares são tão mais complexos do que os genéricos?
Einstein (Säo Paulo)
;
17(1): eED4836, 2019.
Article
in English
| LILACS
| ID: biblio-984361
Subject(s)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Drugs, Generic
/
Drug Compounding
/
Biosimilar Pharmaceuticals
Language:
English
Journal:
Einstein (Säo Paulo)
Journal subject:
Medicine
Year:
2019
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Centro Nacional de Pesquisas em Energia e Materiais/BR
Similar
MEDLINE
...
LILACS
LIS